UK: RQ Bio raises US$115m Series A to advance long-acting antibody programme for full...
RQ Bio, a private biotechnology company developing long-acting antibody therapeutics for the prevention of influenza in high-risk and immunocompromised populations, has completed an oversubscribed...
France: padoa announces growth investment from Thoma Bravo alongside co-founders and existing shareholders, Five...
padoa, a leading occupational health technology platform in France, serving occupational health services, healthcare professionals, employers, and employees through a fully integrated digital ecosystem,...
Europe: Sander Slootweg named chair of Invest Europe
Sander Slootweg, managing partner and co-founder of Forbion, has been appointed chair of Invest Europe for 2026-2027. He most recently chaired Invest Europe’s Venture...
France: Calicéo enters new phase of expansion with €240m in financing
Calicéo, the French leader aquatic well-being, is taking a new step in its development with the completion of more than €240m (US$277m) in financing, including €145m in bank...
Spain: Ona Therapeutics raises US$86.6m Series B to advance First-in-Class ADCs into clinical development
Ona Therapeutics, a Spain-based global biopharmaceutical company pioneering first-in-class ADCs to address treatment-resistant cancers, has closed an oversubscribed US$86.6m Series B financing. The round...
France: Bregal Sagemount and Ardian invest in Ennov’s next phase of growth
Ennov, a France-based global provider of end-to-end regulatory, quality, and clinical software solutions for life sciences and healthcare companies, has received a strategic growth...
Sweden: HealthCap invests in Neobiomics to support continued growth in neonatal care
Neobiomics, a Swedish life science company focused on improving outcomes for preterm infants through evidence-based nutritional products, has received an investment led by HealthCap,...
Belgium: Full-Life Technologies raises US$150m to advance clinical stage assets
Full-Life Technologies, a clinical stage radiotherapeutics company with operations in Belgium, Germany, and China, has raised US$150m led by Vivo Capital. Vivo was joined...
Germany: Verdane supports Eterno’s platform expansion with significant investment
German healthcare technology company, Eterno, has secured a significant investment from Germany-based growth investor, Verdane, in support of the expansion of its AI-native platform...
Netherlands: Capital A secures €515m for Fund V
Capital A, a Netherlands-based investor in companies in the Netherlands, Belgium, and Germany, has announced the close of Capital A Fund V, securing €515m...
Advertisement
